Novartis’ Q4 EPS down 91% to $0.69



Novartis AG announced on Wednesday its earnings per share (EPS) in the fourth quarter of fiscal 2022 dropped 91% on a yearly basis to land at $0.69. Net sales amounted to $12.7 billion, falling 4% in …
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento